PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Bile Salt Export Pump 476 Target Target Multidrug Resistance Protein 1 495 7 0.01 -0.99 0.01 0.74
ACTG1 41 Target Target CALR 117 1 0.01 -0.98 0.02 0.76
Schizophrenia 77,034 Disease Target BDNF 11,163 424 0.01 -0.98 0.04 0.64
Carbonic Anhydrase 3 36 Target Target Glutathione Peroxidase 3 132 1 0.01 -0.98 0.03 0.75
Chronic Pain 21,087 Disease Target Mu Opioid Receptor 4,576 143 0.01 -0.98 0.03 0.67
Chronic Lymphocytic Leukemia 11,642 Disease Target BTK 1,263 56 0.01 -0.98 0.04 0.68
Cancer 1,053,491 Disease Target CHK1 2,044 681 0.01 -0.82 0.33 0.60
BD3 32 Target Target CXCL3 145 1 0.01 -0.98 0.03 0.75
Platelet Aggregation 25,460 Disease Target Phospholipase A2 13,400 272 0.01 -0.98 0.02 0.66
Thromboembolism 23,698 Disease Target Methylenetetrahydrofolate Reductase 3,573 137 0.01 -0.98 0.04 0.67
CD4 112,219 Target Target CXCL9 1,016 159 0.01 -0.92 0.16 0.64
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Target Antithrombin 13,773 7 0.01 -0.75 0.44 0.67
CA 72-4 184 Target Target AFP 9,751 20 0.01 -0.94 0.11 0.68
CD22 1,591 Target Target BAFF 1,240 21 0.01 -0.98 0.02 0.72
CCL14 34 Target Target CXCL11 526 2 0.01 -0.97 0.06 0.73
Schizophrenia 77,034 Disease Target ERBB4 994 131 0.01 -0.93 0.13 0.64
CXCL16 341 Target Target CCL21 808 8 0.02 -0.98 0.02 0.73
Methylenetetrahydrofolate Reductase 3,573 Target Target Antithrombin 13,773 107 0.02 -0.98 0.03 0.68
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
CD137 474 Target Target CD254 9 1 0.02 -0.94 0.11 0.72
Colon Cancer 30,064 Disease Target BRAF 4,766 184 0.02 -0.98 0.04 0.66
bFGF 9,327 Target Target BDNF 11,163 157 0.02 -0.98 0.02 0.69
CXCL7 76 Target Target CCL1 220 2 0.02 -0.98 0.03 0.75
Eotaxin-2/CCL24 19 Target Target CCL1 220 1 0.02 -0.97 0.05 0.74
CD22 1,591 Target Target Ricin 3,034 34 0.02 -0.98 0.02 0.71
CCNB1 160 Target Target AURKC 26 1 0.02 -0.98 0.04 0.75
BLyS 457 Target Target CD254 9 1 0.02 -0.94 0.11 0.73
DDR2 194 Target Target BRAF 4,766 15 0.02 -0.96 0.08 0.70
Cysteinyl Leukotriene Receptor 2 24 Target Target Arachidonate 5-Lipoxygenase 170 1 0.02 -0.98 0.04 0.75
Glutathione S-Transferase A3 15 Target Target Carbonic Anhydrase III 272 1 0.02 -0.96 0.07 0.74
Collagenase-3 367 Target Target Macrophage Metalloelastase 100 3 0.02 -0.98 0.03 0.74
Collagenase 3 367 Target Target Macrophage Metalloelastase 100 3 0.02 -0.98 0.03 0.74
Major Depressive Disorder 12,517 Disease Target BDNF 11,163 186 0.02 -0.98 0.02 0.68
Endoglin 1,333 Target Target Activin A 2,048 26 0.02 -0.98 0.02 0.72
Alpha-1 AntiChymotrypsin 1,460 Target Target AGP 2,006 27 0.02 -0.98 0.02 0.72
BNP 6,842 Target Target Renin 43,456 273 0.02 -0.98 0.04 0.65
Antithrombin 13,773 Target Target Alpha-1 AntiChymotrypsin 1,460 71 0.02 -0.97 0.05 0.68
Alcohol Dehydrogenase 8,492 Target Target Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 113 0.02 -0.98 0.02 0.69
BMP-2 3,889 Target Target Activin A 2,048 45 0.02 -0.98 0.02 0.71
BMP-7 1,112 Target Target BMP-14 14 2 0.02 -0.92 0.14 0.71
Hyperglycemia 28,168 Disease Target Adiponectin 11,994 295 0.02 -0.98 0.02 0.66
CD95 4,266 Target Target Sphingomyelinase 3,060 58 0.02 -0.98 0.02 0.71
CCL19 658 Target Target CXCL3 145 5 0.02 -0.98 0.03 0.73
Epigen 27 Target Target EGF 27,487 14 0.02 -0.69 0.52 0.67
Cholesterol 182,390 Disease Target Sphingomyelinase 3,060 384 0.02 -0.93 0.13 0.63
Eotaxin-3/CCL26 26 Target Target CXCL3 145 1 0.02 -0.98 0.04 0.75
Eotaxin-2/CCL24 19 Target Target CCL8 197 1 0.02 -0.97 0.05 0.75
APOA2 118 Target Target APOC1 126 2 0.02 -0.98 0.02 0.77
Androgen Receptor 12,918 Target Target Steroid 5-Alpha-Reductase 293 32 0.02 -0.94 0.11 0.68
CD4 112,219 Target Target CD137 474 120 0.02 -0.86 0.25 0.64